Urine PD-L1 as a non-invasive biomarker for immune checkpoint inhibitor (ICI) therapy in bladder cancerQianyun Ge, Xuefeng Liu, Cheryl Lee et al.|Advances in Biomarker Sciences and Technology|2025Cited by 1
Conditional Reprogramming: A Living Biomarker and Phenotypic Screening Drug Platform for Urological CancerDanyal Daneshdoust, Xuefeng Liu, Abdul Qawee Rani et al.|Unknown|2025Cited by 0